13 |
Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease[J]. Clin Mol Hepatol, 2014, 20(1): 6-14.
|
14 |
陈俊,刘江涛,孟科,等. 肝硬化食管胃静脉曲张内镜特征与肝静脉压力梯度相关性研究[J]. 胃肠病学和肝病学杂志,2017, 26(11): 1252-1254.
|
15 |
Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the baveno Ⅵ consensus workshop: stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752.
|
16 |
Albilllos A, Garcia-Tsao G. Classification of cirrhosis: the clinical use of HVPG measurements[J]. Dis Markers, 2011, 31(3): 121-128.
|
17 |
Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis[J]. Hepatology, 2010, 51(4): 1445-1449.
|
18 |
Abraldes JG, Villanueva C, Banares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy[J]. J Hepatol, 2008, 48(2): 229-236.
|
19 |
Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding[J]. Gastroenterology, 1999, 117(3): 626-631.
|
20 |
Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding[J]. Lancet, 2003, 361(9361): 952-954.
|
21 |
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J]. Hepatology, 2004, 40(4): 793-801.
|
22 |
Zhang K, Sun X, Wang G, et al. Treatment outcomes of percutaneous transhepatic variceal embolization versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding[J]. Medicine (Baltimore), 2019, 98(18): 15464-15464.
|
23 |
Li GQ, Yang B, Liu J, et al. Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis[J]. Int J Clin Exp Med, 2015, 8(10): 19709-19716.
|
24 |
Zhao Y, Guo L, Huang Q, et al. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient[J]. Medicine (Baltimore), 2019, 98(47): 17900-17900.
|
25 |
Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature[J]. J Vasc Interv Radiol, 2007, 18(4): 463-481.
|
26 |
Chikamori F, Kuniyoshi N, Kawashima T, et al. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism[J]. Hepatogastroenterology, 2007, 54(78): 1847-1849.
|
27 |
李丛勇,刘江涛,郭亮亮,等. 急诊部分性脾栓塞术治疗食管胃静脉曲张破裂出血的初步研究[J]. 胃肠病学和肝病学杂志,2018, 27(11):68-71.
|
28 |
Peng Y, Qi X, Guo X. Child-pugh versus meld score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies[J]. Medicine (Baltimore), 2016, 95(8): 2877-2877.
|
29 |
中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志,2016, 32(2): 203-219.
|
30 |
周嘉宁,魏志,孙自勤. 肝硬化食管静脉曲张套扎后早期再出血相关危险因素的多中心研究[J]. 中华肝脏病杂志,2016, 27(7): 486-492.
|
31 |
Tandon P, Abraldes JG, Keough A, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on child-pugh class, and effects of antibiotics[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1189-1196.
|
32 |
Rudler M, Bureau C, Carbonell N, et al. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding[J]. Liver Int, 2018, 38(3): 469-476.
|
33 |
Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis[J]. Gastroenterology, 2007, 133(2): 481-488.
|
34 |
Lv Y, Zuo L, Zhu X, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study[J]. Gut, 2019, 68(7): 1297-1310.
|
35 |
Abdullah MS, Al-Osaimi, Stephen Caldwell. Medical and endoscopic management of gastric varices[J]. Semin Intervent Radiol, 2011, 28(3): 273-282.
|
36 |
Sanyal AJ, Freedman AM, VA Luketic, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. a randomized, controlled trial[J]. Ann Intern Med, 1997, 126(11): 849-857.
|
37 |
Marion-Audibert AM, Schoeffler M, Wallet F, et al. Acute fatal pulmonary embolism during cyanoacrylate injection in gastric varices[J]. Gastroenterol Clin Biol, 2008, 32(11): 926-930.
|
38 |
Zhao Y, Wang S, Li C, et al. Synchronous hybrid procedure combining interventional radiology and endoscopy for esophagogastric varices with large gastro-renal shunt[J]. Medicine (Baltimore), 2020, 99(17): 19727-19727.
|
39 |
Wu Q, Jiang H, Linghu E, et al. BRTO assisted endoscopic histoacryl injection in treating gastric varices with gastrorenal shunt[J]. Minim Invasive Ther Allied Technol, 2016, 25(6): 337-344.
|
40 |
Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration[J]. J Gastroenterol Hepatol, 1996, 11(1): 51-58.
|
1 |
Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the united states: a population-based study [J]. J Clin Gastroenterol, 2015, 49(8): 690-696.
|
2 |
Berzigotti A. Advances and challenges in cirrhosis and portal hypertension[J]. BMC Med, 2017, 15(1): 200-200.
|
3 |
Mortality GBD, C Causes of Death.Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013[J]. Lancet, 2015, 385(9963): 117-171.
|
4 |
Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades[J]. Hepatology, 2004, 40(3): 652-659.
|
5 |
谭敏. 腹腔镜脾脏切除术治疗门静脉高压症[J/CD]. 中华腔镜外科杂志(电子版), 2010, 3(4): 300-301.
|
6 |
姚英民,拓航,郑鑫,等. 腹腔镜与开腹脾切断流术的临床对比研究[J/CD]. 中华腔镜外科杂志(电子版), 2013, 6(3): 164-168.
|
7 |
Fortune BE, Garcia-Tsao G, Ciarleglio M, et al. Child-turcotte-pugh class is best at stratifying risk in variceal hemorrhage: analysis of a us multicenter prospective study[J]. J Clin Gastroenterol, 2017, 51(5): 446-453.
|
8 |
Amitrano L, Guardascione MA, Manguso F, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors[J]. Am J Gastroenterol, 2012, 107(12): 1872-1878.
|
9 |
Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the american association for the study of liver diseases[J]. Hepatology, 2017, 65(1): 310-335.
|
10 |
Nett A, Binmoeller KF. Endoscopic management of portal hypertension-related bleeding[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 321-337.
|
11 |
Hung ML, Lee EW. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature[J]. Clin Liver Dis, 2019, 23(4): 737-754.
|
12 |
Vorobioff JD, Groszmann RJ. Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage[J]. Ann Hepatol, 2013, 12(1): 22-29.
|